Home / Resource Library / OBINUTUZUMAB AND VENETOCLAX IN UNTREATED UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIAOBINUTUZUMAB AND VENETOCLAX IN UNTREATED UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA EHA 2020